Association of estrogen receptor-α gene polymorphisms with venous thrombosis

Haematologica

Volumn 91, Issue 2, 2006, Pages 279-280

  Lussana, Federico ^a   Faioni, Elena M ^a   Mavilia, Carmelo ^b   Bucciarelli, Paolo ^a   Brandi, Maria Luisa ^b   Cattaneo, Marco ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Estrogen receptor gene; Oral contraceptives; Polymorphisms; Thrombophilia; Venous thrombosis

Indexed keywords

ENDONUCLEASE; ESTROGEN RECEPTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DNA POLYMORPHISM; DNA SCREENING; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SCHOOL CHILD; THROMBOPHILIA;

ADOLESCENT; ADULT; AGED; CHILD; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SEX FACTORS; VENOUS THROMBOSIS;

EID: 33644542762     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Becherini L, Gennari L, Masi L, Mansani R, Massart F, Morelli A, et al. Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor α gene and their relationship to bone mass variation in postmenopausal Italian women. Hum Mol Genet 2000;9:2043-50.
2. Salmen T, Heikkinem AM, Mahonem A, Kroger H, Komulainem M, Saarikoski S, et al. The protective effect of hormone-replacement therapy on fracture risk is modulated by estrogen receptor α genotype in early postmenopausal women. J Bone Miner Res 2000;15:2479-86.
3. Lehtimaki T, Kunnas TA, Mattila KM, Perola M, Penttila A, Koivula T, et al. Coronary artery wall atherosclerosis in relation to the estrogen receptor 1 gene polymorphism: an autopsy study. J Mol Med 2002;80:176-80.
4. Herrington DM, Howard TD, Hawkins GA, Reboussin DM, Xu J, Zheng SL, et al. Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. N Engl J Med 2002;346:967-74.
5. Sudhir K, Chou TM, Chatterjee K, Smith EP, Williams TC, Kane JP, et al. Premature coronary artery disease associated with a disruptive mutation in the estrogen receptor gene in a man. Circulation 1997;96:3774-7.
6. Vandenbroucke JP, Rosing J, Bloemenkamp KW, Middeldorp S, Heimerhorst FM, Bouma BN, et al. Oral contraceptives and the risk of venous thrombosis. N Engl J Med 2001;344:1527-35.
7. Prandoni P, Bilora F, Marchiori A, Bernardi E, Petrobelli F, Lensing AW, et al. An association between atherosclerosis and venous thrombosis. N Engl J Med 2003;348:1435-41.
8. van Meurs JB, Schuit SC, Weel AE, van der Klift M, Bergink AP, Arp PP, et al. Association of 5′ estrogen receptor α gene polymorphisms with bone mineral density, vertebral bone area and fracture risk. Mol Genet 2003;12:1745-54.
9. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998;280:605-13.
10. Shearman AM, Cupples LA, Demissie S, Peter I, Schmid CH, Karas RH et al. Association between estrogen receptor α gene variation and cardiovascular disease. JAMA 2003;290:2263-70.